| Ms Deborah Swenson Morris, MA, CCC-SLP | |
|
370 Monarch Rd, Shelburne, VT 05482-7016 | |
| (802) 373-9132 | |
| Not Available |
| Full Name | Ms Deborah Swenson Morris |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 370 Monarch Rd, Shelburne, Vermont |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508195579 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 12003320 (Vermont) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Deborah Swenson Morris, MA, CCC-SLP 370 Monarch Rd, Shelburne, VT 05482-7016 Ph: (802) 373-9132 | Ms Deborah Swenson Morris, MA, CCC-SLP 370 Monarch Rd, Shelburne, VT 05482-7016 Ph: (802) 373-9132 |
News Archive
University of Pittsburgh Graduate School of Public Health researchers are flipping conventional thought on its head regarding how to improve the health of sedentary people at risk for diabetes and heart disease in a new study designed to combat a condition popularly called "sitting disease."
A newly formed advisory committee will develop and coordinate a strategic federal research agenda on environmental and genetic factors related to breast cancer. The 19 member Interagency Breast Cancer and Environmental Research Coordinating Committee was established by the National Institute of Environmental Health Sciences, in collaboration with the National Cancer Institute, to review all breast cancer research efforts conducted or supported by federal agencies.
Duke University has received a $3.7 million contract from the Biomedical Advanced Research and Development Authority (BARDA) to develop a rapid and accurate genomic-based diagnostic test that can determine if a person has been exposed to radiation from a dirty bomb or nuclear attack. In the event that all option years are exercised by the government, Duke University could receive up to $43.6 million from the contract.
Infinity Pharmaceuticals, Inc. today announced the extension of its global strategic alliance with Mundipharma International Corporation Limited to develop and commercialize IPI-926, Infinity's novel Smoothened antagonist, as well as development candidates arising from Infinity's phosphoinositol-3-kinase (PI3K) and discovery programs.
VaxOnco, a leading oncology biopharmaceutical company, today announced that following FDA IND approval, it will sponsor a Phase I folate receptor alpha-targeted therapeutic vaccine clinical trial in disease-free patients, previously diagnosed with either breast or ovarian cancer at Mayo Clinic.
› Verified 4 days ago
Dr. Nancy Ellen Baker, NANCY BAKER, PH.D. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6773 Dorset St, Shelburne, VT 05482 Phone: 802-985-8188 | |
Ms. Margaret Houston Landry, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4066 Shelburne Rd, Suite 8, Shelburne, VT 05482 Phone: 802-985-8211 Fax: 802-985-8733 | |
Karen Rodgers, MA CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 73 Hillside Terrace, Shelburne, VT 05482 Phone: 215-570-1551 | |
Ms. Justin Mcavoy Lee, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 145 Summerfield Rd, Shelburne, VT 05482 Phone: 802-985-4114 Fax: 802-893-3224 | |
Kathryn Webb, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1611 Harbor Rd, Shelburne, VT 05482 Phone: 802-233-7798 | |
Jessica Decker, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 Wake Robin Dr, Shelburne, VT 05482 Phone: 802-264-5140 |